Rapamycin promotes the anticancer action of dihydroartemisinin in breast cancer MDA-MB-231 cells by regulating expression of Atg7 and DAPK.
about
Rapamycin promotes the anticancer action of dihydroartemisinin in breast cancer MDA-MB-231 cells by regulating expression of Atg7 and DAPK.
description
2018 nî lūn-bûn
@nan
2018年の論文
@ja
2018年学术文章
@wuu
2018年学术文章
@zh
2018年学术文章
@zh-cn
2018年学术文章
@zh-hans
2018年学术文章
@zh-my
2018年学术文章
@zh-sg
2018年學術文章
@yue
2018年學術文章
@zh-hant
name
Rapamycin promotes the antican ...... g expression of Atg7 and DAPK.
@en
Rapamycin promotes the antican ...... g expression of Atg7 and DAPK.
@nl
type
label
Rapamycin promotes the antican ...... g expression of Atg7 and DAPK.
@en
Rapamycin promotes the antican ...... g expression of Atg7 and DAPK.
@nl
prefLabel
Rapamycin promotes the antican ...... g expression of Atg7 and DAPK.
@en
Rapamycin promotes the antican ...... g expression of Atg7 and DAPK.
@nl
P2093
P2860
P356
P1433
P1476
Rapamycin promotes the antican ...... g expression of Atg7 and DAPK.
@en
P2093
Chang Long Li
Qiujun Liu
Xianyao Zhou
Xuemei Zhang
P2860
P304
P356
10.3892/OL.2018.8013
P577
2018-02-09T00:00:00Z